BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1604 related articles for article (PubMed ID: 23878165)

  • 1. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
    Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain.
    Akbar A; Yiangou Y; Facer P; Brydon WG; Walters JR; Anand P; Ghosh S
    Gut; 2010 Jun; 59(6):767-74. PubMed ID: 20551462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR; Jiang K; Zhang QY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
    Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
    Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
    World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
    Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
    Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
    Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
    Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
    Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
    Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
    Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.